Prospective Clinical Assessment Study in Children with Achondroplasia (ACH)
Recruiting in Palo Alto (17 mi)
+30 other locations
Age: < 18
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Recruiting
Sponsor: QED Therapeutics, Inc.
No Placebo Group
Trial Summary
What is the purpose of this trial?This is a long-term, multi-center, observational study in children 2.5 to \<17 years with achondroplasia (ACH). The objective is to evaluate growth, ACH-related medical complications, assessments of health-related quality of life, body pain, functional abilities, cognitive functions, and treatments of study participants. No study medication will be administered.
Eligibility Criteria
Inclusion Criteria
Signed informed consent by study participant or parent(s) or legally authorized representative (LAR) and signed informed assent by the study participant (when applicable)
Aged 2.5 to 10 years (inclusive) at study entry
Diagnosis of ACH
+2 more
Participant Groups
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
University of OttawaOttawa, Canada
Children's Hospital - London Health Sciences CenterLondon, Canada
University of MontrealMontréal, Canada
Benioff Children's Hospital OaklandOakland, CA
More Trial Locations
Loading ...
Who Is Running the Clinical Trial?
QED Therapeutics, Inc.Lead Sponsor